EDEN Insider Trading Activity and SEC Form 4 Filings
EDEN insider trading summary
No open-market insider purchases or sales of Eden Bioscience Corp (EDEN) have been reported on SEC Form 4 in the past 12 months.
Latest EDEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 5, 2009 | Stephen J Heyman | 10% Owner | Buy | $219 (166 @ $1.32) |
| Jun 5, 2009 | Boston Avenue Capital LLC | 10% Owner | Buy | $219 (166 @ $1.32) |
| Jun 5, 2009 | James F Adelson | 10% Owner | Buy | $219 (166 @ $1.32) |
| Jun 5, 2009 | Yorktown Avenue Capital, LLC | 10% Owner | Buy | $219 (166 @ $1.32) |
| Jun 3, 2009 | James F Adelson | 10% Owner | Buy | $2K (1,300 @ $1.32) |
| Jun 3, 2009 | Stephen J Heyman | 10% Owner | Buy | $2K (1,300 @ $1.32) |
| Jun 3, 2009 | Yorktown Avenue Capital, LLC | 10% Owner | Buy | $2K (1,300 @ $1.32) |
| Jun 3, 2009 | Boston Avenue Capital LLC | 10% Owner | Buy | $2K (1,300 @ $1.32) |
| May 28, 2009 | Stephen J Heyman | 10% Owner | Buy | $147 (111 @ $1.32) |
| May 28, 2009 | James F Adelson | 10% Owner | Buy | $147 (111 @ $1.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.